Comparing two fluid removal methods for young children having heart surgery
Part of Immune system & allergy clinical trials.
This study compares two ways of removing extra fluid from the body during heart surgery with a heart-lung machine in children under 5. The goal is to find which method is safer and works better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be under 5 years old.
- Your child is scheduled for heart surgery that uses a heart-lung machine.
- Your child does not have any active infections, autoimmune diseases, or skin conditions like dermatitis.
- Your child has not had a recent viral illness (like COVID or flu) within the past 30 days.
- Your child is not currently taking steroids.
- Your child's surgery is not an emergency and does not require ECMO (a special heart-lung support).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of using the heart-lung machine during heart bypass surgery to see which one causes less inflammation and stress on the body. If you are having planned heart bypass surgery, participating could help doctors understand how to reduce recovery side effects.
This study tests whether adding a special filter (called a cytokine adsorber) to the heart-lung machine during your child's open-heart surgery can reduce harmful inflammation and help them recover better. The filter is used alongside the standard heart-lung machine during the operation.
This study compares two ways of using a heart-lung machine during bypass surgery to see which causes less inflammation in the body. The goal is to help people recover faster and with fewer complications after heart surgery.
This trial tests how well the body responds to a fluid bolus in children who have just had heart surgery. It uses blood gas tests and maybe an ultrasound to guide treatment.
This trial tests whether using a clear fluid to prime the heart-lung machine before surgery reduces inflammation in infants weighing 5-10 kg (about 11-22 pounds). The clear fluid replaces the usual blood-based prime, possibly leading to a smoother recovery after heart surgery.
This trial studies patterns in immune cells (neutrophils) in very young children who undergo heart surgery using a heart-lung machine. The goal is to better understand and potentially reduce lung injury after surgery.
Hear when a new Systemic Inflammatory Response Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.